Zhuoer (Zoey) Xie, Hematologist at Moffitt Cancer Center, shared on X about a recent paper titled: “Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence” published in Blood Journal.
Authors: Zhuoer Xie, Rami S Komrokji, Najla Al-Ali, Alexandra Regelson, Susan Geyer, Anand A Patel, Caner Saygin, Amer M. Zeidan, Jan Philipp Bewersdorf, Lourdes M Mendez, Ashwin Kishtagari, Joshua F. Zeidner, Catherine C. Coombs, Yazan F Madanat, Stephen S Chung, Talha Badar, James M Foran, Pinkal Desai, Charlton Tsai, Elizabeth A. Griffiths, Monzr M. Al Malki, Idoroenyi Amanam, Catherine Lai, H. Joachim Deeg, Lionel Ades, Cecilia Arana-Yi, Afaf EG Osman, Shira Naomi Dinner, Yasmin Abaza, Justin Taylor, Namrata S Chandhok, Deborah Soong, Andrew M. Brunner, Hetty E Carraway, Abhay Singh, Chiara Elena, Jacqueline Ferrari, Anna Galli, Sara Pozzi, Eric Padron, Mrinal M. Patnaik, Luca Malcovati, Michael R. Savona, Aref Al-Kali.
“Exciting News! our study on Risk Prediction for Clonal Cytopenia is out on Blood Journal now! CCRS is easy to use, I hope it proves valuable in your clinics! Importantly, CCRS can shape CCUS management and clinical trial designs!
Last many thanks to the editor and reviewers who are very experienced and detailed in providing constructive feedback and tremendously improve the quality of our manuscript.
This achievement wouldn’t have been possible without the incredible support and encouragement from all our collaborators. These are instrumental in the success of this work. Thank you my friends!
With the rich dataset, we also explored the characteristics of pts with CCMUS, therapy-related CCUS, CCUS with a history of primary cancer, CVD, and inflammatory disease. Thanks to All!Milestone! Two years after our first CH meeting, we Dr. Uma Borate: Associate Professor established the SEARCH consortium — a dedicated team focused on tackling unanswered questions in CH. Proud of what we’ve achieved together and looking forward to the discoveries ahead!” .
Source: Zhuoer Xie/X
